Australia pulls cough/cold products for under 2
This article was originally published in The Tan Sheet
Executive Summary
The Australian Therapeutic Goods Administration follows in the footsteps of FDA and the U.K.'s Medicines and Healthcare products Regulatory Agency by restricting the use of certain OTC cough and cold medicines in children under 2 years of age, according to a memo TGA sent to pharmacists April 10. TGA also tells manufacturers to add labeling warning consumers not to use the products in children under 2. Additionally, TGA advises manufacturers to stop labeling previously approved products for children under 2 as safe, the memo says. The Australian regulatory agency came to its conclusion in part due to FDA's and MHRA's previous decisions to restrict the use of these products in children under 2 (1"The Tan Sheet" March 31, 2008, p. 9)...